MiR-3646 accelerates inflammatory response of Ang II-induced hVSMCs via CYP2J2/EETs axis in hypertension model

References

• Abais-Battad JM, Dasinger JH, Fehrenbach DJ, Mattson DL. Novel adaptive and innate immunity targets in hypertension. Pharmacol Res. 2017;120:109–9. 10.1016/j.phrs.2017.03.015.
   PubMed Web of Science ®Google Scholar
• Mills KT, Stefanescu A, He J. 2020. The global epidemiology of hypertension. Nat Rev Nephrol. 16(4):223–37. doi:10.1038/s41581-019-0244-2
   PubMed Web of Science ®Google Scholar
• Schiffrin EL. 1992. Reactivity of small blood vessels in hypertension: relation with structural changes. State of the art lecture. Hypertension (Dallas, Tex: 1979). 19(2 Suppl):Ii1–9. doi:10.1161/01.hyp.19.2_suppl.ii1-a
   PubMed Web of Science ®Google Scholar
• Dikalov SI, Nazarewicz RR, Bikineyeva A, Hilenski L, Lassègue B, Griendling KK, Harrison DG, Dikalova AE. 2014. Nox2-induced production of mitochondrial superoxide in angiotensin II-mediated endothelial oxidative stress and hypertension. Antioxid Redox Signal. 20(2):281–94. doi:10.1089/ars.2012.4918
   PubMed Web of Science ®Google Scholar
• Touyz RM. 2005. Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II. Curr Opin Nephrol Hypertens. 14(2):125–31. doi:10.1097/00041552-200503000-00007
   PubMed Web of Science ®Google Scholar
• Zhang YH, He K, Shi G. 2017. Effects of MicroRNA-499 on the inflammatory damage of endothelial cells during coronary artery disease via the targeting of PDCD4 through the NF-Κβ/TNF-α signaling pathway. Cell Physiol Biochem: Int J Exp Cell Physiol, Biochem, Pharmacol. 44(1):110–24. doi:10.1159/000484588
   PubMedGoogle Scholar
• Fan JL, Zhang L, Bo XH. 2020. MiR-126 on mice with coronary artery disease by targeting S1PR2. Eur Rev Med Pharmacol Sci. 24(2):893–904. doi:10.26355/eurrev_202001_20074
   PubMed Web of Science ®Google Scholar
• de Yébenes VG, Briones AM, Martos-Folgado I, Mur SM, Oller J, Bilal F, González-Amor M, Méndez-Barbero N, Silla-Castro JC, Were F, et al. 2020. Aging-associated miR-217 aggravates atherosclerosis and promotes cardiovascular dysfunction. Arterioscler Thromb Vasc Biol. 40(10):2408–24. doi:10.1161/atvbaha.120.314333
   PubMed Web of Science ®Google Scholar
• Jiang F, Chen Q, Wang W, Ling Y, Yan Y, Xia P; Jiang F, Chen Q, Wang W, Ling Y, Yan Y, Xia P. Hepatocyte-derived extracellular vesicles promote endothelial inflammation and atherogenesis via microRNA-1. J Hepatol. 2020;72(1):156–66. 10.1016/j.jhep.2019.09.014.
   PubMed Web of Science ®Google Scholar
• Babaee M, Chamani E, Ahmadi R, Bahreini E, Balouchnejadmojarad T, Nahrkhalaji AS, Fallah S. The expression levels of miRNAs- 27a and 23a in the peripheral blood mononuclear cells (PBMCs) and their correlation with FOXO1 and some inflammatory and anti-inflammatory cytokines in the patients with coronary artery disease (CAD). Life Sci. 2020;256:117898. doi:10.1016/j.lfs.2020.117898.
   Web of Science ®Google Scholar
• Tao S, Liu YB, Zhou ZW, Lian B, Li H, Li JP, Zhou SF. miR-3646 promotes cell proliferation, migration, and invasion via regulating G2/M transition in human breast cancer cells. Am J Transl Res. 2016;8(4):1659–77.
   PubMed Web of Science ®Google Scholar
• Wang C, Cheng B. 2022. MicroRNA miR-3646 promotes malignancy of lung adenocarcinoma cells by suppressing sorbin and SH3 domain-containing protein 1 via the c-Jun NH2-terminal kinase signaling pathway. Bioengineered. 13(3):4869–84. doi:10.1080/21655979.2022.2036889
   PubMed Web of Science ®Google Scholar
• Kang X, Cao S, Ji Z, Zhang Y, Sun S, Shang X. miR-3646 promotes vascular inflammation and augments vascular smooth muscle cell proliferation and migration in progression of coronary artery disease by directly targeting RHOH. Int J Clin Exp Pathol. 2018;11(12):5830–39.
   PubMed Web of Science ®Google Scholar
• Lee CM, Lee J, Jang SN, Shon JC, Wu Z, Park K, Liu KH, Park SH. 6,8-diprenylorobol induces apoptosis in human hepatocellular carcinoma cells via activation of FOXO3 and inhibition of CYP2J2. Oxid Med Cell Longev. 2020;(2020):8887251. 10.1155/2020/8887251.
   PubMed Web of Science ®Google Scholar
• Huang XY, Wang YG, Wang Y, Gao Y. 2018. Effect of ophiopogonin D in resisting vascular endothelial cell apoptosis induced by AngIIthrough up-regulating CYP2J2/EETs. Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica. 43(2):377–84. doi:10.19540/j.cnki.cjcmm.20171027.019
   PubMedGoogle Scholar
• Huang X, Wang Y, Zhang Z, Wang Y, Chen X, Wang Y, Gao Y. 2017. Ophiopogonin D and EETs ameliorate Ang II-induced inflammatory responses via activating PPARα in HUVECs. Biochem Biophys Res Commun. 490(2):123–33. doi:10.1016/j.bbrc.2017.06.007
   PubMed Web of Science ®Google Scholar
• Lin H, Chen X, Zhang C, Yang T, Deng Z, Song Y, Huang L, Li F, Li Q, Lin S, et al. EF24 induces ferroptosis in osteosarcoma cells through HMOX1. Biomed Pharmacother. 2021;136:111202. doi:10.1016/j.biopha.2020.111202.
   Web of Science ®Google Scholar
• Li L, Li N, Pang W, Zhang X, Hammock BD, Ai D, Zhu Y, Qin G. 2014. Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis. PLoS one. 9(4):e94092. doi:10.1371/journal.pone.0094092
   PubMed Web of Science ®Google Scholar
• Sun P, Lin D-H, Yue P, Jiang H, Gotlinger KH, Schwartzman ML, Falck JR, Goli M, Wang W-H. 2010. High potassium intake enhances the inhibitory effect of 11,12-EET on ENaC. J Am Soc Nephrol. 21(10):1667–77. doi:10.1681/ASN.2009111110
   PubMed Web of Science ®Google Scholar
• Taherdangkoo K, Kazemi Nezhad SR, Hajjari MR, Tahmasebi Birgani M. 2020. miR-485-3p suppresses colorectal cancer via targeting TPX2. Bratisl Lek Listy. 121(4):302–07. doi:10.4149/bll_2020_048
   PubMed Web of Science ®Google Scholar
• Yang Y, Tian T, Wang Y, Li Z, Xing K, Tian G. SIRT6 protects vascular endothelial cells from angiotensin II-induced apoptosis and oxidative stress by promoting the activation of Nrf2/ARE signaling. Eur J Pharmacol. 2019;859:172516. doi:10.1016/j.ejphar.2019.172516.
   Web of Science ®Google Scholar
• Wang G, Jacquet L, Karamariti E, Xu Q. 2015. Origin and differentiation of vascular smooth muscle cells. J Physiol. 593(14):3013–30. doi:10.1113/jp270033
   PubMed Web of Science ®Google Scholar
• Savoia C, Burger D, Nishigaki N, Montezano A, Touyz RM. Angiotensin II and the vascular phenotype in hypertension. Expert Rev Mol Med. 2011;13:e11. 10.1017/s1462399411001815.
   PubMed Web of Science ®Google Scholar
• Beuzelin D, Kaeffer B. Exosomes and miRNA-loaded biomimetic nanovehicles, a focus on their potentials preventing Type-2 diabetes linked to metabolic syndrome. Front Immunol. 2018;9:2711. doi:10.3389/fimmu.2018.02711.
   Web of Science ®Google Scholar
• Gao F, Kataoka M, Liu N, Liang T, Huang Z-P, Gu F, Ding J, Liu J, Zhang F, Ma Q; Ma Q, Wang Y, Zhang M, Hu X, Kyselovic J, Hu X, Pu WT, Wang J, Chen J, Wang DZ. Therapeutic role of miR-19a/19b in cardiac regeneration and protection from myocardial infarction. Nat Commun. 2019;10(1):1802. 10.1038/s41467-019-09530-1.
   PubMed Web of Science ®Google Scholar
• Li X, Wei Y, Wang Z. 2018. microRNA-21 and hypertension. Hypertension Res: off J Japanese Soc Hypertension. 41(9):649–61. doi:10.1038/s41440-018-0071-z
   Web of Science ®Google Scholar
• Li Y, Ren W, Wang X, Yu X, Cui L, Li X, Zhang X, Shi B. MicroRNA-150 relieves vascular remodeling and fibrosis in hypoxia-induced pulmonary hypertension. Biomed Pharmacother. 2019;109:1740–49. 10.1016/j.biopha.2018.11.058.
   PubMed Web of Science ®Google Scholar
• Nosalski R, Siedlinski M, Denby L, McGinnigle E, Nowak M, Cat AND, Medina-Ruiz L, Cantini M, Skiba D, Wilk G, et al. 2020. T-cell-derived miRNA-214 mediates perivascular fibrosis in hypertension. Circ Res. 126(8):988–1003. doi:10.1161/circresaha.119.315428
   PubMed Web of Science ®Google Scholar
• Lu Q, Ma Z, Ding Y, Bedarida T, Chen L, Xie Z, Song P, Zou M-H; Lu Q, Ma Z, Ding Y, Bedarida T, Chen L, Xie Z, Song P, Zou MH. Circulating miR-103a-3p contributes to angiotensin II-induced renal inflammation and fibrosis via a SNRK/NF-κB/p65 regulatory axis. Nat Commun. 2019;10(1):2145. 10.1038/s41467-019-10116-0.
   PubMedGoogle Scholar
• Ding Y, Tu P, Chen Y, Huang Y, Pan X, Chen W; Ding Y, Tu P, Chen Y, Huang Y, Pan X, Chen W. CYP2J2 and EETs protect against pulmonary arterial hypertension with lung ischemia-reperfusion injury in vivo and in vitro. Respir Res. 2021;22(1):291. 10.1186/s12931-021-01891-w.
   PubMed Web of Science ®Google Scholar
• Fava C, Bonafini S. Eicosanoids via CYP450 and cardiovascular disease: hints from genetic and nutrition studies. Prostaglandins Other Lipid Mediat. 2018;139:41–47. 10.1016/j.prostaglandins.2018.10.001.
   PubMed Web of Science ®Google Scholar
• Feng W, Xu X, Zhao G, Li G, Liu T, Zhao J, Dong R, Wang DW, Tu L. 2013. EETs and CYP2J2 inhibit TNF-α-induced apoptosis in pulmonary artery endothelial cells and TGF-β1-induced migration in pulmonary artery smooth muscle cells. Int J Mol Med. 32(3):685–93. doi:10.3892/ijmm.2013.1435
   PubMed Web of Science ®Google Scholar
• Zheng C, Wang L, Li R, Ma B, Tu L, Xu X, Dackor RT, Zeldin DC, Wang DW. 2010. Gene delivery of cytochrome p450 epoxygenase ameliorates monocrotaline-induced pulmonary artery hypertension in rats. Am J Respir Cell Mol Biol. 43(6):740–49. doi:10.1165/rcmb.2009-0161OC
   PubMed Web of Science ®Google Scholar